| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/27/2005 | WO2005007680A1 Arginine/lysine-enriched peptides |
| 01/27/2005 | WO2005007673A2 Immunogenic peptides |
| 01/27/2005 | WO2005007663A2 Fluorogenic enzyme substrates and uses thereof |
| 01/27/2005 | WO2005007189A1 Subunit vaccine against respiratory syncytial virus infection |
| 01/27/2005 | WO2005007121A2 Mutant interleukin-2(il-2) polypeptides |
| 01/27/2005 | WO2005007078A2 Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars) |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2005006846A2 Generation of plants with altered oil content |
| 01/27/2005 | WO2005006845A2 Generation of plants with altered oil content |
| 01/27/2005 | WO2004108754A3 Herpes simplex virus us11 protein and hipk2 protein complexes and uses thereof |
| 01/27/2005 | WO2004099419A3 Methods and compositions for identifying modulators of g protein-coupled receptors |
| 01/27/2005 | WO2004096846A3 Nogo-b, a regulator of endothelial cell function and vessel remodeling |
| 01/27/2005 | WO2004094671A9 Methods and products for identification and assessment of tlr ligands |
| 01/27/2005 | WO2004074514A3 Method of diagnosis of type 2 diabetes and early onset thereof |
| 01/27/2005 | WO2004067707A3 Administration of transposon-based vectors to reproductive organs |
| 01/27/2005 | WO2004064740A3 Sperm specific lysozyme-like proteins |
| 01/27/2005 | WO2004063222A3 Novel preadipocyte factor-1-like polypeptides |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2004060041A3 Kim-1 antagonists and use to modulate immune system |
| 01/27/2005 | WO2004050851A3 Prion protein ligands and methods of use |
| 01/27/2005 | WO2004050711A3 Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
| 01/27/2005 | WO2004029209A3 Epitope-tagged recombinant growth arrest specific gene 6 protein |
| 01/27/2005 | WO2004028447A3 Novel compositions and methods for the treatment of psoriasis |
| 01/27/2005 | WO2004024756A3 Orthopoxvirus antigens and use thereof |
| 01/27/2005 | WO2003091412A3 Generation of plants with improved pathogen resistance |
| 01/27/2005 | WO2003090687A3 Using heat shock proteins to increase immune response |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003062400A3 Fiber shaft modifications for efficient targeting |
| 01/27/2005 | WO2003054211A3 Receptors for hypersensitive response elicitors and uses thereof |
| 01/27/2005 | WO2002042417A3 Human erg2 potassium channel |
| 01/27/2005 | US20050022265 Enhancing breadmaking quality of flour via increasing expression of puroindoline-b protein in plants; transgenic plants and food processing |
| 01/27/2005 | US20050022262 Control of post-transcriptional gene silencing in plants |
| 01/27/2005 | US20050022260 Genetically engineered avian for use as bioreactors in heterologous protein expression; animal model for disease |
| 01/27/2005 | US20050022259 Genetically engineered embryonic stem cells for use in prevention and treatment of cell proliferfative disorders; gene therapy |
| 01/27/2005 | US20050022257 Transgenic animals harboring appallele having swedish mutation |
| 01/27/2005 | US20050022256 Triple transgenic mouse model of alzheimer's disease |
| 01/27/2005 | US20050021089 Compositions and methods for treating cardiac dysfunction |
| 01/27/2005 | US20050020824 Testis-specific receptor |
| 01/27/2005 | US20050020817 Nucleotide sequences coding tumor marker protein for use as tools in detection, prevention a nd treatment of cell proliferative disorders |
| 01/27/2005 | US20050020816 Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc-globulin and a Gc-globulin medicinal product |
| 01/27/2005 | US20050020815 Gentically engineered serum albumin comprising three-amino acid truncation at its n-terminal and decreased receptivity for trace metals for use in cosmetic and pharmaceutical preparations |
| 01/27/2005 | US20050020813 Streptococcus pneumoniae proteins and nucleic acids |
| 01/27/2005 | US20050020697 Viable nonenzyme protein encapsulation with aerogel. Buffers with gold solution to form gold protein mixture |
| 01/27/2005 | US20050020531 Systemic carnitine deficiency gene and uses thereof |
| 01/27/2005 | US20050020528 Polynucleotide sequence coding hybrid protein; antiinflammatory agents; aids therapy; autoimmune disease |
| 01/27/2005 | US20050020527 Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders |
| 01/27/2005 | US20050020520 DNA vaccine containing tumor-associated gene and cytokine gene and method of preparation the same |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents |
| 01/27/2005 | US20050020497 Mammalian glycoprotein hormone-1 |
| 01/27/2005 | US20050020494 Modified human growth hormone |
| 01/27/2005 | US20050020492 Melanin-concentrating hormone analogs |
| 01/27/2005 | US20050020491 A decorin core protein or a fragment covalently linked to a galactosaminoglycan polysaccharide, and the decorin core protein acts as an anticoagulant and as a carrier for the delivery of an antithrombotic galactosaminoglycan to fibrinogen. |
| 01/27/2005 | US20050020490 Eficiency purification of glucan, mannan, mannan-protein complex from yeasts; reducing antibiotics in animal feeds |
| 01/27/2005 | US20050020486 Product and composition containing a Concholepas concholepas hemocyanin (CCH) subunit, and a method of use thereof |
| 01/27/2005 | US20050020482 Methods for modulating gap junctions |
| 01/27/2005 | US20050019931 Nucleic acids encoding antifungal drug targets and methods of use |
| 01/27/2005 | US20050019929 Deleted adenovirus vectors and methods of making and administering the same |
| 01/27/2005 | US20050019914 Perfusion process for producing erythropoietin |
| 01/27/2005 | US20050019891 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019871 Glycosylated human interferon alpha isoform |
| 01/27/2005 | US20050019870 Monoclonal antibody specific to tuumor associated prostate gene for use diagnostic tool in detection and classification of cell proliferative disorders |
| 01/27/2005 | US20050019869 Chimeric neuropeptide Y receptors |
| 01/27/2005 | US20050019868 Transgenic mouse comprising nucleotide sequences coding transport protein for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019862 Expression vector comprising enzymatic polypeptide for use in prevention and treatment of blood clots; thrombolytic agents |
| 01/27/2005 | US20050019860 Novel C-type lectin and gene thereof |
| 01/27/2005 | US20050019859 Mammalian ceII culture processes for protein production |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019857 Expression vector comprising outer membrane protein F (OMPF) regulatory and gene for use as tools in efficient heterologous gene expression; bioreactors |
| 01/27/2005 | US20050019856 Antifreeze proteins originating in fishes |
| 01/27/2005 | US20050019853 Production of heterologous polypeptides in yeast |
| 01/27/2005 | US20050019840 Non-endogenous, constitutively activated known G protein-coupled receptors |
| 01/27/2005 | US20050019838 Nucleotide sequences coding modular protein domains (PDZ) for use in identifying modulators for treatment of cell proliferative/differentiation, metabolic, immunological or nervous system disorders |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019834 Chemokine alpha 3 |
| 01/27/2005 | US20050019833 Proteins capable of binding to environmental hormones and process for producing the same |
| 01/27/2005 | US20050019832 IGF-1 receptor interacting proteins |
| 01/27/2005 | US20050019830 Methods of screening for TRPM5 modulators |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019824 Fibroblast Growth Factor-10 |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019822 Using presence of short tandem repeat sequence in promoter region of cholecystokinin gene as a diagnostic indicator of panic associated psychological/psychiatric disorders; anxiolytic agents |
| 01/27/2005 | US20050019820 Reagents and methods useful for detecting diseases of the lung |
| 01/27/2005 | US20050019818 Human TBX20 gene and uses |
| 01/27/2005 | US20050019815 Nucleotide sequences coding selenium containing protein for use in diagnosis, prevention and treatment prostate cell proliferative disorders |
| 01/27/2005 | US20050019813 Identifying agents which modulate ubiquination activity ring box protein (RBX1); antitumor agents; enzyme inhibitors |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019810 Nucleotide sequences coding transmembrane protein (TANGO) for use as tool in detection of modulator for prevention and treatment of inflammation and cell proliferative disorders |
| 01/27/2005 | US20050019808 Compositions and methods for regulating mRNA transcription and translation |
| 01/27/2005 | US20050019795 Nucleotide sequences comprising allelic variants coding protease-activated receptor 1 (PAR1) for use as tool in diagnosis, classification, prevention and treatment of heart disease |
| 01/27/2005 | US20050019780 Transforming cells with vector comprising nucleotide sequences coding membrane protein for use in identifying modulators for treatment of metabolic disorders; transmembrane traps; immunodiagnostics |
| 01/27/2005 | US20050019773 Method for producing and identifying soluble protein domains |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019767 Nucleic acid compositions conferring disease resistance |
| 01/27/2005 | US20050019766 Nucleotide sequences coding iron sulfur protein (ISP-1) and or cytochrome b locus (CTB-1) protein for use as tool in detection of modulators for treatment, prevention or ameloriation of developmental, behavioral, reproductive and aging disorders |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |